Tasso and partners receive $4.25M to develop a universal surveillance platform for infectious disease outbreaks
Tasso simplifies blood draws, awarded $3M expansion
September 28, 2017
Tasso, Inc. (Tasso), Ceres Nanosciences (Ceres), George Mason University (Mason), and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced the commencement of an $11.7 million program, funded by the Defense Threat Reduction Agency (DTRA), to develop a reliable, safe, and simple universal surveillance platform for infectious disease outbreaks.
Tasso, Inc. simplifies blood sampling, secures $2.3M
April 7, 2015
Tasso, Inc., a medtech start-up developing the HemoLink™, a small disposable device to simplify blood sampling, has secured an additional $2.9M in grant funding to advance its HemoLink technology with its development partner GenTegra LLC.
Feb 3, 2014
Tasso, Inc., a medtech start-up developing a wearable blood draw device, has secured $2.3M in grant funding for its HemoLink™ technology.